In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.61 in the prior trading day, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $8.39, down -2.56%. In other words, the price has decreased by -$2.56 from its previous closing price. On the day, 1.64 million shares were traded. MRVI stock price reached its highest trading level at $8.96 during the session, while it also had its lowest trading level at $8.37.
Ratios:
Our goal is to gain a better understanding of MRVI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.28 and its Current Ratio is at 10.00. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.
On August 13, 2024, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also lowered its target price recommendation from $11 to $10.
On April 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.Craig Hallum initiated its Buy rating on April 10, 2024, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 28 ’24 when GTCR INVESTMENT XI LLC sold 9,940,974 shares for $9.81 per share. The transaction valued at 97,570,660 led to the insider holds 20,150,005 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 2116268416 and an Enterprise Value of 1562572544. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.26 while its Price-to-Book (P/B) ratio in mrq is 2.72. Its current Enterprise Value per Revenue stands at 5.609 whereas that against EBITDA is 755.962.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is -3.85%, while the 200-Day Moving Average is calculated to be 8.47%.
Shares Statistics:
The stock has traded on average 2.40M shares per day over the past 3-months and 1786830 shares per day over the last 10 days, according to various share statistics. A total of 132.23M shares are outstanding, with a floating share count of 117.52M. Insiders hold about 16.98% of the company’s shares, while institutions hold 90.00% stake in the company. Shares short for MRVI as of 1724976000 were 8375611 with a Short Ratio of 3.49, compared to 1722384000 on 7920248. Therefore, it implies a Short% of Shares Outstanding of 8375611 and a Short% of Float of 7.06.
